Bilateral adrenal metastases from malignant melanoma: Concordant findings on 18F-FDG and 18F-FDOPA PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 7, 2006, Pages 854-855

  Seshadri, Nagabhushan ^a   Wat, Josephine ^a   Balan, Kottekkattu ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; FLUORODEOXYGLUCOSE F 18;

ADRENAL METASTASIS; ADRENAL TUMOR; ADULT; ARTICLE; CASE REPORT; CATECHOLAMINE URINE LEVEL; DIAGNOSTIC IMAGING; DOPAMINE RELEASE; DRUG UPTAKE; HUMAN; MALE; MELANOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY;

ADRENAL GLAND NEOPLASMS; DIHYDROXYPHENYLALANINE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MELANOMA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SKIN NEOPLASMS;

EID: 33745526433     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0101-y     Document Type: Article

References (5)

1. Wansaicheong G, Goh J. Adrenal metastases. eMedicine, Omaha, 2002 [cited June 2003]. Available from URL: http://www.emedicine.com/radio/topic17.htm
2. DasGupta T, Brasfield R. Metastatic melanoma: a clinicopathological study. Cancer 1964;10:1323-9
3. Patel JK, Didolkar MS, Pickeren JW, Moore RH. Metastatic pattern of malignant melanoma: a study of 216 autopsy cases. Am J Surg 1978;135:807-10
4. Kumar R, Mavi A, Bural G, Alavi A. Fluorodeoxyglucose-PET in the management of malignant melanoma. Radiol Clin North Am 2005;43:23-33
5. 15O-water using compartment and non-compartment analysis. J Nucl Med 2001;42(2):257-8